Top compounds associated with response to CBSL


Feature Type Standardized
Nominal ANOVA
mRNA linifanib CTRPv2 pan-cancer AAC 0.11 0.003
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.099 0.003
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.096 0.004
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.11 0.004
mRNA hyperforin CTRPv2 pan-cancer AAC 0.12 0.004
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.11 0.004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.005
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.11 0.005
Download CSV